Please assess the completion status of the following clinical trial:

Trial Title: Continuous Infusion of Terlipressin in Septic Shock

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of Septic shock~* vasopressor support to maintain mean arterial pressure (MAP) between 65 and 75 mmHg despite adequate volume resuscitation (pulmonary artery occlusion pressure = 13-18 mmHg and central venous pressure = 8-12 mmHg)~Exclusion Criteria:~* Pregnancy~* Present cardiac dysfunction~* Present or suspected acute mesenteric ischemia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Terlipressin
- 2 (Type: EXPERIMENTAL): Vasopressin
- 3 (Type: ACTIVE_COMPARATOR): titrated norepinephrine

Based on this trial design, predict the completion outcome and termination type (if applicable).